Journals / Nöropsikiyatri Arşivi / 2015 / Cilt: 52 - Sayı: 4

Renal Transplantasyonlu Hastalarda Görülen Nörolojik Komplikasyonlar: Retrospektif Klinik Çalışma

Neurological Complications after Renal Transplantation: A Retrospective Clinical Study

Pages
331–335
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

NCs seen after RT can be treated by decreasing the dose or changing the immunosuppressive drug.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The aim of this study was to evaluate the incidence and types of neurological complications (NCs) and associated factors in renal transplantation (RT) patients.
📊
Key Findings & Data:Methods: Three hundred and forty-four patients who had RT performed at our institution between January 2005 and July 2014 were retrospectively evaluated.
💡
Conclusion & Impact:NCs seen after RT can be treated by decreasing the dose or changing the immunosuppressive drug.
🔬Design:Research Article
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: The aim of this study was to evaluate the incidence and types of neurological complications (NCs) and associated factors in renal transplantation (RT) patients. Methods: Three hundred and forty-four patients who had RT performed at our institution between January 2005 and July 2014 were retrospectively evaluated. Results: File records of the patients revealed 19 who experienced a total of 22 episodes of NCs, of whom three had more than one episode. The mean age of 19 patients included in the study, of whom eight were female, was 37.52±13.08 (range, 18-65) years. NCs were classified into central or peripheral depending on the location of involvement of the central nervous system (CNS). CNS involvement was found in 16 (84.2%) of the 19 patients. Tremor (36.8%) was the most common CNS complication in these patients. Encephalopathy, generalized tonic-clonic seizures, and status epilepticus were observed in two patients (10.5%). Delirium and dementia were observed in one patient (5.2%). Headache was experienced by one patient, and agitated depression was observed in one patient. Six patients (26.3%) had the peripheral nervous system involvement. One patient had the numbness of hands with normal electromyography findings, and four patients had polyneuropathy. In one patient, lumbar plexopathy was observed. Seventeen of the 22 NCs were considered to be caused by immunosuppressive agents. Each incidence of amyloidosis, infection, septic emboli, and hypoglycemia caused a neurological episode. The etiology of one episode was unknown. Conclusion: Different neurological disorders can be seen after RT, and most of them are caused by immunosuppressive drugs. NCs seen after RT can be treated by decreasing the dose or changing the immunosuppressive drug.

Özet

Amaç: Bu çalışmanın amacı renal transplantasyon yapılan hastalarda görülen nörolojik komplikasyonların tipini, sıklığını ve ilişkili faktörleri araştırmaktır. Yöntem: Çalışmada Ocak 2005 ile Temmuz 2014 tarihleri arasında has-tanemizde renal transpalantasyon yapılmış 344 hastanın dosya bilgileri ret-rospektif olarak incelendi.Bulgular: Ondokuz hastada 22 nörolojik komplikasyon atağı saptandı. Üç hastada birden fazla atak ortaya çıktı. Çalışmaya dahil edilen ve sekizi kadın olan 19 hastanın, yaş ortalamaları 37,52±13,08 (18-65) yıldı. Nörolojik komplikasyonlar santral ve periferik sistem tutulumu olarak sınıflandırıldı. Ondokuz hastanın 16'sında (%84,2) santral sinir sistemi tutulumu gözlen-di. Bu hastalarda en sık görülen komplikasyon (%36,8) tremordu. Jener-alize tonik-klonik status epileptikus, tonik-klonik nöbet ve ensefalopati 2 (%10,5) olguda görüldü. Bir hastada deliryum ve demans (%5,2), ajite depresyon (%5,2) ve başağrısı birer hastada görüldü. Periferik sinir sistemi tutulumu 6 (%26,3) hastada görüldü. Bu hastaların birinde ellerde duyusal semptomlar olmasına rağmen elektronöromiyografi normaldi. 4 hastada periferik nöropati ve bir hastada lomber pleksopati saptandı. Hastalarda gözlenen 22 nörolojik komplikasyonun 17'si immünsupresan ilaçlara bağlı olarak ortaya çıkmıştı. Amiloidoz, enfeksiyon, septik emboli and hipo-glisemi birer hastada nörolojik komplikasyon nedeni olarak saptandı. Bir hastada atak nedeni saptanamadı. Sonuç: Renal transplantasyon sonrası farklı nörolojik komplikasyonlar or-taya çıkabilir ve bu komplikasyonların çoğu immünosupresif ilaçlara bağlıdır, ilaç dozunun azaltılması veya değiştirilmesi ile düzeltilebilir.

🔖

Cite This Article

CENGİZ, N., ADIBELLİ, Z., YAKUPOĞLU, Y. K., TÜRKER, H. (2015). Renal Transplantasyonlu Hastalarda Görülen Nörolojik Komplikasyonlar: Retrospektif Klinik Çalışma. Nöropsikiyatri Arşivi, Cilt: 52 - Sayı: 4, 331–335. https://ajindex.com/articles/292375

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Ponticelli C, Campise MR. Neurological complications in kidney transplant re- cipients. J Nephrol 2005; 18:521-528.
  2. Bruno A, Adams HP Jr. Neurologic problems in renal transplant recipients. Neurol Clin 1988; 6:305-325.
  3. Lee JM, Raps EC. Neurologic complications of transplantation. Neurol Clin 1998; 16:21-33. [CrossRef] Ce P, Koskderelioglu A, Coban G, Gedizlioglu M, Nart A, Uslu A. Neurolog- ic complications of renal transplant. Exp Clin Transplant 2012; 10:243-246. [CrossRef] Yardimci N, Colak T, Sevmis S, Benli S, Zileli T, Haberal M. Neurologic compli- cations after renal transplant. Exp Clin Transplant 2008; 6:224-228.
  4. Mayer AD, Dmitrewski J, Squifflet JP, Besse T, Grabensee B, Klein B, Eigler FW, Heemann U, Pichlmayr R, Behrend M, Vanrenterghem Y, Donck J, van Hooff J, Christiaans M, Morales JM, Andres A, Johnson RW, Short C, Buchholz B, Reh- mert N, Land W, Schleibner S, Forsythe JL, Talbot D, Pohanka E. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the pre- vention of renal allograft rejection: a report of the European Tacrolimus Multi- center Renal Study Group. Transplantation 1997; 64:436-443. [CrossRef] Neylan JF, Sullivan EM, Steinwald B, Goss TF. Assessment of the frequency and costs of posttransplantation hospitalizations in patients receiving tacrolimus versus cyclosporine. Am J Kidney Dis 1998; 32:770-777. [CrossRef] Veroux P, Veroux M, Puliatti C, Morale W, Cappello D, Valvo M, Macarone M. Tacrolimus-induced neurotoxicity in kidney transplant recipients. Transplant Proc 2002; 34:3188-3190. [CrossRef] Bechstein WO. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 2000; 13:313-326. [CrossRef] Kastrup O, Schlamann M, Moenninghoff C, Forsting M, Goericke S. Posterior Reversible Encephalopathy Syndrome: The Spectrum of MR Imaging Patterns. Clin Neuroradiol 2014 Feb 20. Wu G, Weng FL, Balaraman V. Tacrolimus-induced encephalopathy and poly- neuropathy in a renal transplant recipient. BMJ Case Rep 2013; 2013.
  5. Cadavid-Aljure D, Caicedo-Paredes A, Meza JC, Granados-Sánchez AM, Posa- da-Chávez JG, Mesa-Ramírez L, Schweineberg-López J. Tacrolimus associated to posterior reversible atypical encephalopathy syndrome and brain haemor- rhage in renal transplant recipient. Nefrologia 2012; 32:861-863.
  6. Chegounchi M, Hanna MG, Neild GH. Progressive neurological disease in- duced by tacrolimus in a renal transplant recipient: case presentation. BMC Nephrol 2006; 7:7. [CrossRef] Kastrup O, Gerwi